ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumor Markers Immunoassay Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-18U6138
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Tumor Markers Immunoassay Market Insights and Forecast to 2028
BUY CHAPTERS

Global Tumor Markers Immunoassay Market Research Report 2024

Code: QYRE-Auto-18U6138
Report
August 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Clarity Diagnostics, LLC
CTK Biotech, Inc
Dialab
Ortho Clinical Diagnostics
Polymedco
DIAsource ImmunoAssays SA
DRG International, Inc
Fujirebio US, Inc
Bioscience (Tianjin) Diagnostic Technology Co., Ltd
Boson Biotech Co., Ltd
Qualigen
Randox Laboratories Ltd.
Roche Diagnostic Corporation
Siemens Healthineers
Syntron Bioresearch, Inc
Teco Diagnostics
Thermo Fisher Scientific Inc
Tosoh Bioscience, Inc
Diametra
DiaSorin

Tumor Markers Immunoassay Market

The global Tumor Markers Immunoassay market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tumor Markers Immunoassay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tumor Markers Immunoassay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Tumor Markers Immunoassay in Liver Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Tumor Markers Immunoassay include Clarity Diagnostics, LLC, CTK Biotech, Inc, DIALAB GmbH, Ortho Clinical Diagnostics, Polymedco, Inc, DIAsource ImmunoAssays SA, DRG International, Inc, Fujirebio US, Inc and Bioscience (Tianjin) Diagnostic Technology Co., Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor Markers Immunoassay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Markers Immunoassay.

Report Scope

The Tumor Markers Immunoassay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Markers Immunoassay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Markers Immunoassay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tumor Markers Immunoassay Market Report

Report Metric Details
Report Name Tumor Markers Immunoassay Market
Segment by Type
  • ProGRP
  • PSA (complexed, free, total))
  • SCC (squamous cell carcinoma antigen)
  • Serum HER-2/neu
  • Thyroglobulin
  • CA 72-4
  • Others
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Clarity Diagnostics, LLC, CTK Biotech, Inc, DIALAB GmbH, Ortho Clinical Diagnostics, Polymedco, Inc, DIAsource ImmunoAssays SA, DRG International, Inc, Fujirebio US, Inc, Bioscience (Tianjin) Diagnostic Technology Co., Ltd, Boson Biotech Co., Ltd, Qualigen, Inc, Randox Laboratories, Ltd, Roche Diagnostic Corporation, Siemens Healthineers, Syntron Bioresearch, Inc, Teco Diagnostics, Thermo Fisher Scientific, Inc, Tosoh Bioscience, Inc, Diametra, DiaSorin S.p.A
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Tumor Markers Immunoassay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tumor Markers Immunoassay Market report?

Ans: The main players in the Tumor Markers Immunoassay Market are Clarity Diagnostics, LLC, CTK Biotech, Inc, DIALAB GmbH, Ortho Clinical Diagnostics, Polymedco, Inc, DIAsource ImmunoAssays SA, DRG International, Inc, Fujirebio US, Inc, Bioscience (Tianjin) Diagnostic Technology Co., Ltd, Boson Biotech Co., Ltd, Qualigen, Inc, Randox Laboratories, Ltd, Roche Diagnostic Corporation, Siemens Healthineers, Syntron Bioresearch, Inc, Teco Diagnostics, Thermo Fisher Scientific, Inc, Tosoh Bioscience, Inc, Diametra, DiaSorin S.p.A

What are the Application segmentation covered in the Tumor Markers Immunoassay Market report?

Ans: The Applications covered in the Tumor Markers Immunoassay Market report are Liver Cancer, Breast Cancer, Others

What are the Type segmentation covered in the Tumor Markers Immunoassay Market report?

Ans: The Types covered in the Tumor Markers Immunoassay Market report are ProGRP, PSA (complexed, free, total)), SCC (squamous cell carcinoma antigen), Serum HER-2/neu, Thyroglobulin, CA 72-4, Others

Recommended Reports

Cancer Diagnostics

Tumor Marker Testing

Biomarkers & Assays

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Markers Immunoassay Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ProGRP
1.2.3 PSA (complexed, free, total))
1.2.4 SCC (squamous cell carcinoma antigen)
1.2.5 Serum HER-2/neu
1.2.6 Thyroglobulin
1.2.7 CA 72-4
1.2.8 Others
1.3 Market by Application
1.3.1 Global Tumor Markers Immunoassay Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Liver Cancer
1.3.3 Breast Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Markers Immunoassay Market Perspective (2019-2030)
2.2 Tumor Markers Immunoassay Growth Trends by Region
2.2.1 Global Tumor Markers Immunoassay Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tumor Markers Immunoassay Historic Market Size by Region (2019-2024)
2.2.3 Tumor Markers Immunoassay Forecasted Market Size by Region (2025-2030)
2.3 Tumor Markers Immunoassay Market Dynamics
2.3.1 Tumor Markers Immunoassay Industry Trends
2.3.2 Tumor Markers Immunoassay Market Drivers
2.3.3 Tumor Markers Immunoassay Market Challenges
2.3.4 Tumor Markers Immunoassay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Markers Immunoassay Players by Revenue
3.1.1 Global Top Tumor Markers Immunoassay Players by Revenue (2019-2024)
3.1.2 Global Tumor Markers Immunoassay Revenue Market Share by Players (2019-2024)
3.2 Global Tumor Markers Immunoassay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Markers Immunoassay Revenue
3.4 Global Tumor Markers Immunoassay Market Concentration Ratio
3.4.1 Global Tumor Markers Immunoassay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Markers Immunoassay Revenue in 2023
3.5 Tumor Markers Immunoassay Key Players Head office and Area Served
3.6 Key Players Tumor Markers Immunoassay Product Solution and Service
3.7 Date of Enter into Tumor Markers Immunoassay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Markers Immunoassay Breakdown Data by Type
4.1 Global Tumor Markers Immunoassay Historic Market Size by Type (2019-2024)
4.2 Global Tumor Markers Immunoassay Forecasted Market Size by Type (2025-2030)
5 Tumor Markers Immunoassay Breakdown Data by Application
5.1 Global Tumor Markers Immunoassay Historic Market Size by Application (2019-2024)
5.2 Global Tumor Markers Immunoassay Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tumor Markers Immunoassay Market Size (2019-2030)
6.2 North America Tumor Markers Immunoassay Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tumor Markers Immunoassay Market Size by Country (2019-2024)
6.4 North America Tumor Markers Immunoassay Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Markers Immunoassay Market Size (2019-2030)
7.2 Europe Tumor Markers Immunoassay Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tumor Markers Immunoassay Market Size by Country (2019-2024)
7.4 Europe Tumor Markers Immunoassay Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Markers Immunoassay Market Size (2019-2030)
8.2 Asia-Pacific Tumor Markers Immunoassay Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tumor Markers Immunoassay Market Size by Region (2019-2024)
8.4 Asia-Pacific Tumor Markers Immunoassay Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Markers Immunoassay Market Size (2019-2030)
9.2 Latin America Tumor Markers Immunoassay Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tumor Markers Immunoassay Market Size by Country (2019-2024)
9.4 Latin America Tumor Markers Immunoassay Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Markers Immunoassay Market Size (2019-2030)
10.2 Middle East & Africa Tumor Markers Immunoassay Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tumor Markers Immunoassay Market Size by Country (2019-2024)
10.4 Middle East & Africa Tumor Markers Immunoassay Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Clarity Diagnostics, LLC
11.1.1 Clarity Diagnostics, LLC Company Detail
11.1.2 Clarity Diagnostics, LLC Business Overview
11.1.3 Clarity Diagnostics, LLC Tumor Markers Immunoassay Introduction
11.1.4 Clarity Diagnostics, LLC Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.1.5 Clarity Diagnostics, LLC Recent Development
11.2 CTK Biotech, Inc
11.2.1 CTK Biotech, Inc Company Detail
11.2.2 CTK Biotech, Inc Business Overview
11.2.3 CTK Biotech, Inc Tumor Markers Immunoassay Introduction
11.2.4 CTK Biotech, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.2.5 CTK Biotech, Inc Recent Development
11.3 DIALAB GmbH
11.3.1 DIALAB GmbH Company Detail
11.3.2 DIALAB GmbH Business Overview
11.3.3 DIALAB GmbH Tumor Markers Immunoassay Introduction
11.3.4 DIALAB GmbH Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.3.5 DIALAB GmbH Recent Development
11.4 Ortho Clinical Diagnostics
11.4.1 Ortho Clinical Diagnostics Company Detail
11.4.2 Ortho Clinical Diagnostics Business Overview
11.4.3 Ortho Clinical Diagnostics Tumor Markers Immunoassay Introduction
11.4.4 Ortho Clinical Diagnostics Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.4.5 Ortho Clinical Diagnostics Recent Development
11.5 Polymedco, Inc
11.5.1 Polymedco, Inc Company Detail
11.5.2 Polymedco, Inc Business Overview
11.5.3 Polymedco, Inc Tumor Markers Immunoassay Introduction
11.5.4 Polymedco, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.5.5 Polymedco, Inc Recent Development
11.6 DIAsource ImmunoAssays SA
11.6.1 DIAsource ImmunoAssays SA Company Detail
11.6.2 DIAsource ImmunoAssays SA Business Overview
11.6.3 DIAsource ImmunoAssays SA Tumor Markers Immunoassay Introduction
11.6.4 DIAsource ImmunoAssays SA Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.6.5 DIAsource ImmunoAssays SA Recent Development
11.7 DRG International, Inc
11.7.1 DRG International, Inc Company Detail
11.7.2 DRG International, Inc Business Overview
11.7.3 DRG International, Inc Tumor Markers Immunoassay Introduction
11.7.4 DRG International, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.7.5 DRG International, Inc Recent Development
11.8 Fujirebio US, Inc
11.8.1 Fujirebio US, Inc Company Detail
11.8.2 Fujirebio US, Inc Business Overview
11.8.3 Fujirebio US, Inc Tumor Markers Immunoassay Introduction
11.8.4 Fujirebio US, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.8.5 Fujirebio US, Inc Recent Development
11.9 Bioscience (Tianjin) Diagnostic Technology Co., Ltd
11.9.1 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Company Detail
11.9.2 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Business Overview
11.9.3 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Tumor Markers Immunoassay Introduction
11.9.4 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.9.5 Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Development
11.10 Boson Biotech Co., Ltd
11.10.1 Boson Biotech Co., Ltd Company Detail
11.10.2 Boson Biotech Co., Ltd Business Overview
11.10.3 Boson Biotech Co., Ltd Tumor Markers Immunoassay Introduction
11.10.4 Boson Biotech Co., Ltd Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.10.5 Boson Biotech Co., Ltd Recent Development
11.11 Qualigen, Inc
11.11.1 Qualigen, Inc Company Detail
11.11.2 Qualigen, Inc Business Overview
11.11.3 Qualigen, Inc Tumor Markers Immunoassay Introduction
11.11.4 Qualigen, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.11.5 Qualigen, Inc Recent Development
11.12 Randox Laboratories, Ltd
11.12.1 Randox Laboratories, Ltd Company Detail
11.12.2 Randox Laboratories, Ltd Business Overview
11.12.3 Randox Laboratories, Ltd Tumor Markers Immunoassay Introduction
11.12.4 Randox Laboratories, Ltd Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.12.5 Randox Laboratories, Ltd Recent Development
11.13 Roche Diagnostic Corporation
11.13.1 Roche Diagnostic Corporation Company Detail
11.13.2 Roche Diagnostic Corporation Business Overview
11.13.3 Roche Diagnostic Corporation Tumor Markers Immunoassay Introduction
11.13.4 Roche Diagnostic Corporation Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.13.5 Roche Diagnostic Corporation Recent Development
11.14 Siemens Healthineers
11.14.1 Siemens Healthineers Company Detail
11.14.2 Siemens Healthineers Business Overview
11.14.3 Siemens Healthineers Tumor Markers Immunoassay Introduction
11.14.4 Siemens Healthineers Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.14.5 Siemens Healthineers Recent Development
11.15 Syntron Bioresearch, Inc
11.15.1 Syntron Bioresearch, Inc Company Detail
11.15.2 Syntron Bioresearch, Inc Business Overview
11.15.3 Syntron Bioresearch, Inc Tumor Markers Immunoassay Introduction
11.15.4 Syntron Bioresearch, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.15.5 Syntron Bioresearch, Inc Recent Development
11.16 Teco Diagnostics
11.16.1 Teco Diagnostics Company Detail
11.16.2 Teco Diagnostics Business Overview
11.16.3 Teco Diagnostics Tumor Markers Immunoassay Introduction
11.16.4 Teco Diagnostics Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.16.5 Teco Diagnostics Recent Development
11.17 Thermo Fisher Scientific, Inc
11.17.1 Thermo Fisher Scientific, Inc Company Detail
11.17.2 Thermo Fisher Scientific, Inc Business Overview
11.17.3 Thermo Fisher Scientific, Inc Tumor Markers Immunoassay Introduction
11.17.4 Thermo Fisher Scientific, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.17.5 Thermo Fisher Scientific, Inc Recent Development
11.18 Tosoh Bioscience, Inc
11.18.1 Tosoh Bioscience, Inc Company Detail
11.18.2 Tosoh Bioscience, Inc Business Overview
11.18.3 Tosoh Bioscience, Inc Tumor Markers Immunoassay Introduction
11.18.4 Tosoh Bioscience, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.18.5 Tosoh Bioscience, Inc Recent Development
11.19 Diametra
11.19.1 Diametra Company Detail
11.19.2 Diametra Business Overview
11.19.3 Diametra Tumor Markers Immunoassay Introduction
11.19.4 Diametra Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.19.5 Diametra Recent Development
11.20 DiaSorin S.p.A
11.20.1 DiaSorin S.p.A Company Detail
11.20.2 DiaSorin S.p.A Business Overview
11.20.3 DiaSorin S.p.A Tumor Markers Immunoassay Introduction
11.20.4 DiaSorin S.p.A Revenue in Tumor Markers Immunoassay Business (2019-2024)
11.20.5 DiaSorin S.p.A Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Clarity Diagnostics, LLC
CTK Biotech, Inc
Dialab
Ortho Clinical Diagnostics
Polymedco
DIAsource ImmunoAssays SA
DRG International, Inc
Fujirebio US, Inc
Bioscience (Tianjin) Diagnostic Technology Co., Ltd
Boson Biotech Co., Ltd
Qualigen
Randox Laboratories Ltd.
Roche Diagnostic Corporation
Siemens Healthineers
Syntron Bioresearch, Inc
Teco Diagnostics
Thermo Fisher Scientific Inc
Tosoh Bioscience, Inc
Diametra
DiaSorin
List of Tables
    Table 1. Global Tumor Markers Immunoassay Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of ProGRP
    Table 3. Key Players of PSA (complexed, free, total))
    Table 4. Key Players of SCC (squamous cell carcinoma antigen)
    Table 5. Key Players of Serum HER-2/neu
    Table 6. Key Players of Thyroglobulin
    Table 7. Key Players of CA 72-4
    Table 8. Key Players of Others
    Table 9. Global Tumor Markers Immunoassay Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Tumor Markers Immunoassay Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 11. Global Tumor Markers Immunoassay Market Size by Region (2019-2024) & (US$ Million)
    Table 12. Global Tumor Markers Immunoassay Market Share by Region (2019-2024)
    Table 13. Global Tumor Markers Immunoassay Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 14. Global Tumor Markers Immunoassay Market Share by Region (2025-2030)
    Table 15. Tumor Markers Immunoassay Market Trends
    Table 16. Tumor Markers Immunoassay Market Drivers
    Table 17. Tumor Markers Immunoassay Market Challenges
    Table 18. Tumor Markers Immunoassay Market Restraints
    Table 19. Global Tumor Markers Immunoassay Revenue by Players (2019-2024) & (US$ Million)
    Table 20. Global Tumor Markers Immunoassay Market Share by Players (2019-2024)
    Table 21. Global Top Tumor Markers Immunoassay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Markers Immunoassay as of 2023)
    Table 22. Ranking of Global Top Tumor Markers Immunoassay Companies by Revenue (US$ Million) in 2023
    Table 23. Global 5 Largest Players Market Share by Tumor Markers Immunoassay Revenue (CR5 and HHI) & (2019-2024)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Tumor Markers Immunoassay Product Solution and Service
    Table 26. Date of Enter into Tumor Markers Immunoassay Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Tumor Markers Immunoassay Market Size by Type (2019-2024) & (US$ Million)
    Table 29. Global Tumor Markers Immunoassay Revenue Market Share by Type (2019-2024)
    Table 30. Global Tumor Markers Immunoassay Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 31. Global Tumor Markers Immunoassay Revenue Market Share by Type (2025-2030)
    Table 32. Global Tumor Markers Immunoassay Market Size by Application (2019-2024) & (US$ Million)
    Table 33. Global Tumor Markers Immunoassay Revenue Market Share by Application (2019-2024)
    Table 34. Global Tumor Markers Immunoassay Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 35. Global Tumor Markers Immunoassay Revenue Market Share by Application (2025-2030)
    Table 36. North America Tumor Markers Immunoassay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Tumor Markers Immunoassay Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Tumor Markers Immunoassay Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Tumor Markers Immunoassay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Europe Tumor Markers Immunoassay Market Size by Country (2019-2024) & (US$ Million)
    Table 41. Europe Tumor Markers Immunoassay Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Asia-Pacific Tumor Markers Immunoassay Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Asia-Pacific Tumor Markers Immunoassay Market Size by Region (2019-2024) & (US$ Million)
    Table 44. Asia-Pacific Tumor Markers Immunoassay Market Size by Region (2025-2030) & (US$ Million)
    Table 45. Latin America Tumor Markers Immunoassay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Latin America Tumor Markers Immunoassay Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Latin America Tumor Markers Immunoassay Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Middle East & Africa Tumor Markers Immunoassay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 49. Middle East & Africa Tumor Markers Immunoassay Market Size by Country (2019-2024) & (US$ Million)
    Table 50. Middle East & Africa Tumor Markers Immunoassay Market Size by Country (2025-2030) & (US$ Million)
    Table 51. Clarity Diagnostics, LLC Company Detail
    Table 52. Clarity Diagnostics, LLC Business Overview
    Table 53. Clarity Diagnostics, LLC Tumor Markers Immunoassay Product
    Table 54. Clarity Diagnostics, LLC Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 55. Clarity Diagnostics, LLC Recent Development
    Table 56. CTK Biotech, Inc Company Detail
    Table 57. CTK Biotech, Inc Business Overview
    Table 58. CTK Biotech, Inc Tumor Markers Immunoassay Product
    Table 59. CTK Biotech, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 60. CTK Biotech, Inc Recent Development
    Table 61. DIALAB GmbH Company Detail
    Table 62. DIALAB GmbH Business Overview
    Table 63. DIALAB GmbH Tumor Markers Immunoassay Product
    Table 64. DIALAB GmbH Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 65. DIALAB GmbH Recent Development
    Table 66. Ortho Clinical Diagnostics Company Detail
    Table 67. Ortho Clinical Diagnostics Business Overview
    Table 68. Ortho Clinical Diagnostics Tumor Markers Immunoassay Product
    Table 69. Ortho Clinical Diagnostics Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 70. Ortho Clinical Diagnostics Recent Development
    Table 71. Polymedco, Inc Company Detail
    Table 72. Polymedco, Inc Business Overview
    Table 73. Polymedco, Inc Tumor Markers Immunoassay Product
    Table 74. Polymedco, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 75. Polymedco, Inc Recent Development
    Table 76. DIAsource ImmunoAssays SA Company Detail
    Table 77. DIAsource ImmunoAssays SA Business Overview
    Table 78. DIAsource ImmunoAssays SA Tumor Markers Immunoassay Product
    Table 79. DIAsource ImmunoAssays SA Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 80. DIAsource ImmunoAssays SA Recent Development
    Table 81. DRG International, Inc Company Detail
    Table 82. DRG International, Inc Business Overview
    Table 83. DRG International, Inc Tumor Markers Immunoassay Product
    Table 84. DRG International, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 85. DRG International, Inc Recent Development
    Table 86. Fujirebio US, Inc Company Detail
    Table 87. Fujirebio US, Inc Business Overview
    Table 88. Fujirebio US, Inc Tumor Markers Immunoassay Product
    Table 89. Fujirebio US, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 90. Fujirebio US, Inc Recent Development
    Table 91. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Company Detail
    Table 92. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Business Overview
    Table 93. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Tumor Markers Immunoassay Product
    Table 94. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 95. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Recent Development
    Table 96. Boson Biotech Co., Ltd Company Detail
    Table 97. Boson Biotech Co., Ltd Business Overview
    Table 98. Boson Biotech Co., Ltd Tumor Markers Immunoassay Product
    Table 99. Boson Biotech Co., Ltd Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 100. Boson Biotech Co., Ltd Recent Development
    Table 101. Qualigen, Inc Company Detail
    Table 102. Qualigen, Inc Business Overview
    Table 103. Qualigen, Inc Tumor Markers Immunoassay Product
    Table 104. Qualigen, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 105. Qualigen, Inc Recent Development
    Table 106. Randox Laboratories, Ltd Company Detail
    Table 107. Randox Laboratories, Ltd Business Overview
    Table 108. Randox Laboratories, Ltd Tumor Markers Immunoassay Product
    Table 109. Randox Laboratories, Ltd Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 110. Randox Laboratories, Ltd Recent Development
    Table 111. Roche Diagnostic Corporation Company Detail
    Table 112. Roche Diagnostic Corporation Business Overview
    Table 113. Roche Diagnostic Corporation Tumor Markers Immunoassay Product
    Table 114. Roche Diagnostic Corporation Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 115. Roche Diagnostic Corporation Recent Development
    Table 116. Siemens Healthineers Company Detail
    Table 117. Siemens Healthineers Business Overview
    Table 118. Siemens Healthineers Tumor Markers Immunoassay Product
    Table 119. Siemens Healthineers Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 120. Siemens Healthineers Recent Development
    Table 121. Syntron Bioresearch, Inc Company Detail
    Table 122. Syntron Bioresearch, Inc Business Overview
    Table 123. Syntron Bioresearch, Inc Tumor Markers Immunoassay Product
    Table 124. Syntron Bioresearch, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 125. Syntron Bioresearch, Inc Recent Development
    Table 126. Teco Diagnostics Company Detail
    Table 127. Teco Diagnostics Business Overview
    Table 128. Teco Diagnostics Tumor Markers Immunoassay Product
    Table 129. Teco Diagnostics Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 130. Teco Diagnostics Recent Development
    Table 131. Thermo Fisher Scientific, Inc Company Detail
    Table 132. Thermo Fisher Scientific, Inc Business Overview
    Table 133. Thermo Fisher Scientific, Inc Tumor Markers Immunoassay Product
    Table 134. Thermo Fisher Scientific, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 135. Thermo Fisher Scientific, Inc Recent Development
    Table 136. Tosoh Bioscience, Inc Company Detail
    Table 137. Tosoh Bioscience, Inc Business Overview
    Table 138. Tosoh Bioscience, Inc Tumor Markers Immunoassay Product
    Table 139. Tosoh Bioscience, Inc Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 140. Tosoh Bioscience, Inc Recent Development
    Table 141. Diametra Company Detail
    Table 142. Diametra Business Overview
    Table 143. Diametra Tumor Markers Immunoassay Product
    Table 144. Diametra Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 145. Diametra Recent Development
    Table 146. DiaSorin S.p.A Company Detail
    Table 147. DiaSorin S.p.A Business Overview
    Table 148. DiaSorin S.p.A Tumor Markers Immunoassay Product
    Table 149. DiaSorin S.p.A Revenue in Tumor Markers Immunoassay Business (2019-2024) & (US$ Million)
    Table 150. DiaSorin S.p.A Recent Development
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tumor Markers Immunoassay Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Tumor Markers Immunoassay Market Share by Type: 2023 VS 2030
    Figure 3. ProGRP Features
    Figure 4. PSA (complexed, free, total)) Features
    Figure 5. SCC (squamous cell carcinoma antigen) Features
    Figure 6. Serum HER-2/neu Features
    Figure 7. Thyroglobulin Features
    Figure 8. CA 72-4 Features
    Figure 9. Others Features
    Figure 10. Global Tumor Markers Immunoassay Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 11. Global Tumor Markers Immunoassay Market Share by Application: 2023 VS 2030
    Figure 12. Liver Cancer Case Studies
    Figure 13. Breast Cancer Case Studies
    Figure 14. Others Case Studies
    Figure 15. Tumor Markers Immunoassay Report Years Considered
    Figure 16. Global Tumor Markers Immunoassay Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 17. Global Tumor Markers Immunoassay Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Tumor Markers Immunoassay Market Share by Region: 2023 VS 2030
    Figure 19. Global Tumor Markers Immunoassay Market Share by Players in 2023
    Figure 20. Global Top Tumor Markers Immunoassay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Markers Immunoassay as of 2023)
    Figure 21. The Top 10 and 5 Players Market Share by Tumor Markers Immunoassay Revenue in 2023
    Figure 22. North America Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. North America Tumor Markers Immunoassay Market Share by Country (2019-2030)
    Figure 24. United States Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Tumor Markers Immunoassay Market Share by Country (2019-2030)
    Figure 28. Germany Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Asia-Pacific Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Asia-Pacific Tumor Markers Immunoassay Market Share by Region (2019-2030)
    Figure 36. China Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Japan Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. South Korea Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Southeast Asia Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. India Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Australia Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Latin America Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Latin America Tumor Markers Immunoassay Market Share by Country (2019-2030)
    Figure 44. Mexico Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Brazil Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Tumor Markers Immunoassay Market Share by Country (2019-2030)
    Figure 48. Turkey Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Saudi Arabia Tumor Markers Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Clarity Diagnostics, LLC Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 51. CTK Biotech, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 52. DIALAB GmbH Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 53. Ortho Clinical Diagnostics Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 54. Polymedco, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 55. DIAsource ImmunoAssays SA Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 56. DRG International, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 57. Fujirebio US, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 58. Bioscience (Tianjin) Diagnostic Technology Co., Ltd Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 59. Boson Biotech Co., Ltd Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 60. Qualigen, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 61. Randox Laboratories, Ltd Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 62. Roche Diagnostic Corporation Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 63. Siemens Healthineers Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 64. Syntron Bioresearch, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 65. Teco Diagnostics Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 66. Thermo Fisher Scientific, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 67. Tosoh Bioscience, Inc Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 68. Diametra Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 69. DiaSorin S.p.A Revenue Growth Rate in Tumor Markers Immunoassay Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Tumor Markers Detection Kit Market Research Report 2025
Global Tumor Marker Detection Products Market Insights Forecast to 2030
Global Rapid Tumor Marker Tests Market Research Report 2025
Global Tumor Marker Testing Market Research Report 2024
Global Tumor Biomarker Test Market Research Report 2024
Global Breast Biopsy Marker Market Research Report 2024
Global Breast Tissue Markers Market Research Report 2024
Global Point of care Testing POCT for Tumor Marker Market Research Report 2024
Global Tumor Marker Test Kit Market Research Report 2025
Global Bone Marker Market Research Report 2024
Global Biomarkers for Signing Cancer Market Research Report 2025
Global Neuronal Markers Market Research Report 2025
Global Breast Biopsy Site Marker Market Insights Forecast to 2030
Global Cardiac Marker Market Research Report 2024
Global Antibodies in Oncology Market Research Report 2024
Global Marker Bands Market Research Report 2024
Global Solid Tumor Detection Market Research Report 2024
Global Human Immunoassay Market Research Report 2025
Global Enzyme Markers Market Research Report 2024
Cell Surface Markers Market
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions